Home > Boards > US Listed > Biotechs > BIONDVAX PHARMACUETICALS LTD (BVXV)

Could you see if the Hebrew clearly states

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 110
Posts 24,076
Boards Moderated 14
Alias Born 02/07/04
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/1/2020 8:20:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/1/2020 6:32:00 AM
Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial PR Newswire (US) - 7/1/2020 6:00:00 AM
BiondVax Announces First Quarter 2020 Financial Results PR Newswire (US) - 6/30/2020 4:01:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/22/2020 1:37:36 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/12/2020 8:11:32 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 6/12/2020 8:04:57 AM
BiondVax Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update PR Newswire (US) - 6/12/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2020 7:48:38 AM
NIH Report on Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Concludes Both Primary Endpoin... PR Newswire (US) - 6/10/2020 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/20/2020 7:44:36 AM
BiondVax Announces Receipt of $4.2 Million Through Exercise of Warrants PR Newswire (US) - 5/20/2020 6:30:00 AM
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... Edgar (US Regulatory) - 5/13/2020 4:34:19 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/4/2020 10:48:44 AM
BiondVax Announces Upcoming Expiration of Public Warrants PR Newswire (US) - 5/4/2020 6:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/30/2020 9:40:42 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/24/2020 4:28:59 PM
New Directors Elected to BiondVax's Board of Directors PR Newswire (US) - 3/24/2020 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2020 1:06:02 PM
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial PR Newswire (US) - 3/19/2020 7:15:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/25/2020 12:42:30 PM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 2/10/2020 5:22:43 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/10/2020 11:15:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/5/2020 3:25:39 PM
Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Va... PR Newswire (US) - 2/5/2020 1:00:00 PM
midastouch017   Wednesday, 04/29/20 02:08:31 AM
Re: Spideyboy post# 296
Post # of 373 
Quote:
Could you see if the Hebrew clearly states the Dr herself stating the product could be used for coronaviruses or Covid?



Prof. Ruth Arnon's reply is unequivocal,
loud and very clear:

Q/Does corona also have flu-like symptoms?
Is it a similar disease?

A/"The corona is quite different from the flu,
even though it causes similar symptoms. The
anti-flu vaccine we developed has no chance of
working against the corona."

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist